No Data
Beyond The Numbers: 15 Analysts Discuss Marvell Tech Stock
Oppenheimer Maintains Marvell Technology(MRVL.US) With Buy Rating, Raises Target Price to $110
Marvell Tech Analyst Ratings
Today's Analyst Rating | UnitedHealth Price Target Raised to $655 by RBC Capital, Citi Upgrades Chevron to Buy
Express News | Marvell Technology Inc : Oppenheimer Raises Target Price to $110 From $90
Wells Fargo Maintains Marvell Technology(MRVL.US) With Buy Rating, Raises Target Price to $110